China Pharma Holdings (CPHI) Receivables - Net: 2009-2025
Historic Receivables - Net for China Pharma Holdings (CPHI) over the last 17 years, with Sep 2025 value amounting to $294,514.
- China Pharma Holdings' Receivables - Net fell 97.94% to $294,514 in Q3 2025 from the same period last year, while for Sep 2025 it was $294,514, marking a year-over-year decrease of 97.94%. This contributed to the annual value of $13.8 million for FY2024, which is 3.30% down from last year.
- Per China Pharma Holdings' latest filing, its Receivables - Net stood at $294,514 for Q3 2025, which was down 97.88% from $13.9 million recorded in Q2 2025.
- In the past 5 years, China Pharma Holdings' Receivables - Net registered a high of $14.3 million during Q4 2023, and its lowest value of $275,244 during Q2 2023.
- For the 3-year period, China Pharma Holdings' Receivables - Net averaged around $9.1 million, with its median value being $13.9 million (2025).
- Its Receivables - Net has fluctuated over the past 5 years, first skyrocketed by 4,972.20% in 2024, then tumbled by 97.94% in 2025.
- Over the past 5 years, China Pharma Holdings' Receivables - Net (Quarterly) stood at $714,475 in 2021, then plummeted by 41.00% to $421,531 in 2022, then skyrocketed by 3,290.15% to $14.3 million in 2023, then declined by 3.30% to $13.8 million in 2024, then plummeted by 97.94% to $294,514 in 2025.
- Its last three reported values are $294,514 in Q3 2025, $13.9 million for Q2 2025, and $13.9 million during Q1 2025.